{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:54:35Z","timestamp":1776387275900,"version":"3.51.2"},"reference-count":36,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T00:00:00Z","timestamp":1297987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T00:00:00Z","timestamp":1297987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30873088"],"award-info":[{"award-number":["30873088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,23]]},"DOI":"10.1016\/j.febslet.2010.12.045","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T09:26:36Z","timestamp":1298107596000},"page":"881-887","source":"Crossref","is-referenced-by-count":25,"title":["Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line"],"prefix":"10.1002","volume":"585","author":[{"given":"Yixue","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guopei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,2,18]]},"reference":[{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0005|feb2s0014579311001189-cit-b0005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1586\/14737140.6.7.1111","article-title":"Head and neck cancer: past, present and future","volume":"6","author":"Chin","year":"2006","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0010|feb2s0014579311001189-cit-b0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","article-title":"Cancer statistics, 1999","volume":"49","author":"Landis","year":"1999","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0015|feb2s0014579311001189-cit-b0015","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/1097-0142(19901015)66:8<1688::AID-CNCR2820660806>3.0.CO;2-K","article-title":"A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies","volume":"66","author":"Saltz","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0020|feb2s0014579311001189-cit-b0020","first-page":"6501","article-title":"Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line","volume":"52","author":"Esaki","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0025|feb2s0014579311001189-cit-b0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1254\/jjp.87.41","article-title":"The upregulation by peplomycin of signal transduction in human cells","volume":"87","author":"Yamamoto","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0030|feb2s0014579311001189-cit-b0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1368-8375(00)00101-9","article-title":"Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity","volume":"37","author":"Okamura","year":"2001","journal-title":"Oral Oncol."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0035|feb2s0014579311001189-cit-b0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.oraloncology.2003.09.012","article-title":"Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention","volume":"40","author":"Hsu","year":"2004","journal-title":"Oral Oncol."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0040|feb2s0014579311001189-cit-b0040","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0045|feb2s0014579311001189-cit-b0045","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M","article-title":"Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity","volume":"51","author":"Yamamoto","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0050|feb2s0014579311001189-cit-b0050","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2174\/1568026043387746","article-title":"Growth factor signaling and resistance to cancer chemotherapy","volume":"4","author":"Dai","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0055|feb2s0014579311001189-cit-b0055","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1111\/j.1742-4658.2010.07836.x","article-title":"Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells","volume":"277","author":"Zheng","year":"2010","journal-title":"Febs J."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0060|feb2s0014579311001189-cit-b0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1097-2765(01)80002-2","article-title":"RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo","volume":"3","author":"Misteli","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0065|feb2s0014579311001189-cit-b0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ijc.21874","article-title":"Id-1 promotes proliferation of p53-deficient esophageal cancer cells","volume":"119","author":"Hui","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0070|feb2s0014579311001189-cit-b0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/hyb.2009.0003","article-title":"A novel monoclonal antibody specific to DIXDC1 protein","volume":"28","author":"Liu","year":"2009","journal-title":"Hybridoma (Larchmt)"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0075|feb2s0014579311001189-cit-b0075","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/1087057104265386","article-title":"Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines","volume":"9","author":"Mueller","year":"2004","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0080|feb2s0014579311001189-cit-b0080","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0085|feb2s0014579311001189-cit-b0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pep.2006.12.007","article-title":"High-yield expression in Escherichia coli of soluble human MT2A with native functions","volume":"53","author":"Yang","year":"2007","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0090|feb2s0014579311001189-cit-b0090","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/14786410802417107","article-title":"Apoptotic cell death of human leukaemia U937 cells by ubiquinone-9 purified from Pleurotus eryngii","volume":"23","author":"Bae","year":"2009","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0095|feb2s0014579311001189-cit-b0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.0.CO;2-N","article-title":"Amplification of oncogenes in human cancer cells","volume":"20","author":"Schwab","year":"1998","journal-title":"BioEssays"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0100|feb2s0014579311001189-cit-b0100","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1073\/pnas.172285799","article-title":"High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells","volume":"99","author":"Huang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0105|feb2s0014579311001189-cit-b0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1568011053352587","article-title":"Cisplatin resistance and transcription factors","volume":"5","author":"Torigoe","year":"2005","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0110|feb2s0014579311001189-cit-b0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001813-200301000-00006","article-title":"Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model","volume":"14","author":"Knapp","year":"2003","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0115|feb2s0014579311001189-cit-b0115","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.cellsig.2008.06.007","article-title":"Identification of phosphorylation sites on transcription factor Sp1 in response to DNA damage and its accumulation at damaged sites","volume":"20","author":"Iwahori","year":"2008","journal-title":"Cell Signal."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0120|feb2s0014579311001189-cit-b0120","unstructured":""},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0125|feb2s0014579311001189-cit-b0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.taap.2007.12.020","article-title":"Suppression of a DNA base excision repair gene, hOGG1, increases bleomycin sensitivity of human lung cancer cell line","volume":"228","author":"Wu","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0130|feb2s0014579311001189-cit-b0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00204-008-0325-7","article-title":"Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats","volume":"83","author":"Helal","year":"2009","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0135|feb2s0014579311001189-cit-b0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1368-7646(02)00047-X","article-title":"Molecular aspects of resistance to antitumor platinum drugs","volume":"5","author":"Brabec","year":"2002","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0140|feb2s0014579311001189-cit-b0140","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0021-9258(17)42175-2","article-title":"Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair","volume":"269","author":"Chu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0145|feb2s0014579311001189-cit-b0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.drup.2004.08.002","article-title":"Molecular mechanisms of platinum resistance. still searching for the Achilles&rsquo; heel","volume":"7","author":"Wernyj","year":"2004","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0150|feb2s0014579311001189-cit-b0150","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1124\/mol.60.6.1153","article-title":"Identification of genes that mediate sensitivity to cisplatin","volume":"60","author":"Niedner","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0155|feb2s0014579311001189-cit-b0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1477-7827-1-66","article-title":"Chemoresistance in human ovarian cancer: the role of apoptotic regulators","volume":"1","author":"Fraser","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0160|feb2s0014579311001189-cit-b0160","doi-asserted-by":"crossref","first-page":"23477","DOI":"10.1074\/jbc.M313709200","article-title":"Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models","volume":"279","author":"Mabuchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0165|feb2s0014579311001189-cit-b0165","doi-asserted-by":"crossref","first-page":"19245","DOI":"10.1074\/jbc.M208134200","article-title":"Sustained activation of JNK\/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells","volume":"278","author":"Mansouri","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0170|feb2s0014579311001189-cit-b0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2005.07.046","article-title":"Role of copper transporters in the uptake and efflux of platinum containing drugs","volume":"234","author":"Safaei","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0175|feb2s0014579311001189-cit-b0175","first-page":"3059","article-title":"Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132: involvement of NF-kappaB activation in drug resistance","volume":"58","author":"Lin","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.febslet.2010.12.045-BIB2s0014579311001189-bib-b0180|feb2s0014579311001189-cit-b0180","first-page":"7081","article-title":"P53 is a determinant of X-linked inhibitor of apoptosis protein\/Akt-mediated chemoresistance in human ovarian cancer cells","volume":"63","author":"Fraser","year":"2003","journal-title":"Cancer Res."}],"container-title":["FEBS Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.febslet.2010.12.045","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.febslet.2010.12.045","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1016\/j.febslet.2010.12.045\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T04:45:56Z","timestamp":1637297156000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1016\/j.febslet.2010.12.045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,18]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,3,23]]}},"URL":"https:\/\/doi.org\/10.1016\/j.febslet.2010.12.045","archive":["Portico"],"relation":{},"ISSN":["0014-5793"],"issn-type":[{"value":"0014-5793","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,18]]}}}